Study
WES of mCRC xenografts under cetuximab treatment, placebo or after treatment release
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001003764 | Other |
Study Description
Determine if cetuximab treatment selects any pre-existing resistant subclones or if the resistant cells, which in vivo determines residual disease, are driven by plasticity effects not linked to mutations.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001005186 |
WES on cetuximab treated, untreated and release samples of two metastatic colorectal xenografts.
First case: 3 cetuximab treated samples, 3 placebo and 3 release.
Second case: 2 cetuximab treated samples, 2 placebo and 3 release.
Paired fastq.
|
Illumina HiSeq 2500 | 16 |
Who archives the data?
